Hi, buddies!
These standards are not obligatory and might not be modified anytime soon. When it came time to make a decision, the Narcotic Enforcement Administration decided against reclassifying marijuana as a Schedule II drug like Oxycodone or Ritalin.
As a result, the FDA agreed to encourage further in-depth research on marijuana and simplify the process for analysts. Without sure, further research is needed if we're going to be able to advise physicians and patients on how to use cannabis safely and effectively, according to Bonn-Miller.
These standards are not obligatory and might not be modified anytime soon. When it came time to make a decision, the Narcotic Enforcement Administration decided against reclassifying marijuana as a Schedule II drug like Oxycodone or Ritalin.
As a result, the FDA agreed to encourage further in-depth research on marijuana and simplify the process for analysts. Without sure, further research is needed if we're going to be able to advise physicians and patients on how to use cannabis safely and effectively, according to Bonn-Miller.